Skip to Content
  • Previous Rank447
  • Revenues ($M)$6,878
  • Revenue Percent Change19.9%
  • Profits ($M)$115
  • Profits Percent Change-70.3%
  • Assets ($M)$21,208
  • Employees50,000
  • Market Value — as of March 31, 2017 ($M)$18,999

The global contract-research firm conducts clinical trials and other activities for pharmaceutical companies.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

CEO
Ari Bousbib
CEO Title
Chairman, President & Chief Executive Officer
Sector
Health Care
Industry
Health Care: Pharmacy and Other Services
HQ Location
Durham, NC
Websitehttp://www.quintilesims.com
Years on Fortune 500 List4
Employees50,000
Acquired IMS Health Holdings (2015 rank: 746), Oct. 3, 2016.

Quintiles IMS Holdings Rank History

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$6,87819.9%
Profits ($M)$115-70.3%
Assets ($M)$21,208-
Total Stockholder Equity ($M)$8,633-
Market Value — as of March 31, 2017 ($M)$18,999-

Profit Ratios

Profit as % of Revenues1.7%
Profits as % of Assets0.5%
Profits as % of Stockholder Equity1.3%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)0.76
EPS % Change (from 2015)-75.3%
EPS % Change (5 year annual rate)-
EPS % Change (10 year annual rate)-

Total Return

Total Return to Investors (2016)10.8%
Total Return to Investors (5 year, annualized)-
Total Return to Investors (10 year, annualized)-